- Home
- LNTH vs LBTYK Comparison
LNTH vs LBTYK Comparison
Compare LNTH & LBTYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- LBTYK
- Stock Information
- Founded
- LNTH 1956
- LBTYK 2004
- Country
- LNTH United States
- LBTYK Bermuda
- Employees
- LNTH N/A
- LBTYK N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LBTYK Cable & Other Pay Television Services
- Sector
- LNTH Health Care
- LBTYK Telecommunications
- Exchange
- LNTH Nasdaq
- LBTYK Nasdaq
- Market Cap
- LNTH 3.8B
- LBTYK 4.1B
- IPO Year
- LNTH 2015
- LBTYK N/A
- Fundamental
- Price
- LNTH $52.93
- LBTYK $10.85
- Analyst Decision
- LNTH Buy
- LBTYK
- Analyst Count
- LNTH 6
- LBTYK 0
- Target Price
- LNTH $74.17
- LBTYK N/A
- AVG Volume (30 Days)
- LNTH 1.3M
- LBTYK 1.1M
- Earning Date
- LNTH 11-06-2025
- LBTYK 01-01-0001
- Dividend Yield
- LNTH N/A
- LBTYK N/A
- EPS Growth
- LNTH N/A
- LBTYK N/A
- EPS
- LNTH 2.39
- LBTYK N/A
- Revenue
- LNTH $1,525,933,000.00
- LBTYK $4,770,600,000.00
- Revenue This Year
- LNTH N/A
- LBTYK $13.25
- Revenue Next Year
- LNTH $1.98
- LBTYK $1.75
- P/E Ratio
- LNTH $22.15
- LBTYK N/A
- Revenue Growth
- LNTH 1.95
- LBTYK 170.50
- 52 Week Low
- LNTH $47.25
- LBTYK $9.21
- 52 Week High
- LNTH $111.29
- LBTYK $14.83
- Technical
- Relative Strength Index (RSI)
- LNTH 44.38
- LBTYK 43.22
- Support Level
- LNTH $50.16
- LBTYK $10.76
- Resistance Level
- LNTH $55.55
- LBTYK $11.29
- Average True Range (ATR)
- LNTH 2.69
- LBTYK 0.38
- MACD
- LNTH -0.40
- LBTYK 0.01
- Stochastic Oscillator
- LNTH 24.18
- LBTYK 32.02
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.